Tampa General Hospital (TGH), the primary teaching hospital for the USF Health Morsani College of Medicine, has announced its Cancer Institute earned a three-year accreditation from the Commission on Cancer (CoC), a quality program established ...
Tevogen Bio, a late-stage clinical biotechnology company specializing in the development of cellular immunotherapies in oncology, neurology, and virology has announced its intention to study potential therapeutic use of its allogeneic genetically unmodified precision T ...
Syndax Pharmaceuticals, a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, has announced the appointment of Steve Sabus to the role of Chief Commercial Officer (CCO), effective December 5, 2022. Mr. Sabus brings ...
Popular Posts
